Wells Fargo’s Benitec Biopharma BNTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $87.5K | Buy |
+7,478
| New | +$87.5K | ﹤0.01% | 4867 |
|
|
2024
Q2 | – | Sell |
-17
| Closed | -$89 | – | 6545 |
|
|
2024
Q1 | $89 | Hold |
17
| – | – | ﹤0.01% | 6296 |
|
|
2023
Q4 | $55 | Buy |
17
+4
| +31% | +$13 | ﹤0.01% | 6469 |
|
|
2023
Q3 | $39 | Buy |
13
+1
| +8% | +$3 | ﹤0.01% | 6609 |
|
|
2023
Q2 | $48 | Buy |
12
+1
| +9% | +$4 | ﹤0.01% | 6755 |
|
|
2023
Q1 | $41 | Hold |
11
| – | – | ﹤0.01% | 6840 |
|
|
2022
Q4 | $32 | Buy |
11
+8
| +267% | +$23 | ﹤0.01% | 6814 |
|
|
2022
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 6343 |
|
|
2022
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 6511 |
|
|
2022
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 6675 |
|
|
2021
Q4 | $0 | Buy |
3
+1
| +50% | – | ﹤0.01% | 6661 |
|
|
2021
Q3 | $0 | Sell |
2
-1
| -33% | – | ﹤0.01% | 6629 |
|
|
2021
Q2 | $0 | Buy |
3
+1
| +50% | – | ﹤0.01% | 6548 |
|
|
2021
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 6507 |
|
|
2020
Q4 | $0 | Buy |
+2
| New | – | ﹤0.01% | 6131 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 5963 |
|